Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Recombinant Proteins Market, by Product
1.4.2 North America Recombinant Proteins Market, by End User
1.4.3 North America Recombinant Proteins Market, by Application
1.4.4 North America Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. North America Recombinant Proteins Market by Product
4.1 North America Growth Factors & Chemokines Market by Country
4.2 North America Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 North America Structural Proteins Market by Country
4.4 North America Membrane Proteins Market by Country
4.5 North America Kinase Proteins & Regulatory Proteins Market by Country
4.6 North America Immune Response Proteins Market by Country
4.7 North America Others Market by Country
Chapter 5. North America Recombinant Proteins Market by End User
5.1 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 North America Biotechnology Companies Market by Country
5.3 North America Academic Research Institutes Market by Country
5.4 North America Contract Research Organizations Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Recombinant Proteins Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Academic Research Studies Market by Country
6.3 North America Biopharmaceutical Production Market by Country
6.4 North America Diagnostics Market by Country
6.5 North America Biotechnology Research Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Recombinant Proteins Market by Country
7.1 US Recombinant Proteins Market
7.1.1 US Recombinant Proteins Market by Product
7.1.2 US Recombinant Proteins Market by End User
7.1.3 US Recombinant Proteins Market by Application
7.2 Canada Recombinant Proteins Market
7.2.1 Canada Recombinant Proteins Market by Product
7.2.2 Canada Recombinant Proteins Market by End User
7.2.3 Canada Recombinant Proteins Market by Application
7.3 Mexico Recombinant Proteins Market
7.3.1 Mexico Recombinant Proteins Market by Product
7.3.2 Mexico Recombinant Proteins Market by End User
7.3.3 Mexico Recombinant Proteins Market by Application
7.4 Rest of North America Recombinant Proteins Market
7.4.1 Rest of North America Recombinant Proteins Market by Product
7.4.2 Rest of North America Recombinant Proteins Market by End User
7.4.3 Rest of North America Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
Unique Offerings 
